期刊文献+

散发性大肠腺癌易感性与吸烟和GSTT1空白基因型

Correlation of GSTT1 gene polymorphism and smoking with susceptibility to sporadic colorectal adenocarcinoma in China
下载PDF
导出
摘要 目的:探讨谷胱甘肽S-转移酶(GST)T1空白基因型和吸烟与散发性大肠腺癌(SCRAC)遗传易感性关联. 方法:应用多重PCR技术,检测GSTT1基因多态性. 结果:GSTT1空白基因型在吸烟大于10支/d的对照组和SCRAC组中的频率差异有显著性(X2=5.35,P=0.021), 在重度吸烟的远端SCRAC(X2=6.48,P=0.011)、非老年人SCRAC(X2=4.53,P=0.033)及低分化肿瘤(X2=4.02, P=0.045)与重度吸烟的对照组之间的频率差异均有显著性,不同Dukes分期重度吸烟的SCRAC分别与重度吸烟的对照组比较,GSTT1空白基因型频率的差异无显著性. 结论:GSTT1空白基因型提高了重度吸烟的个体患SCRAC 的危险陛,GSTT1空白基因型与重度吸烟的远端SCRAC 的易感性之间存在关联,肿瘤多见于非老年患者,多呈低分化性腺癌. AIM: To analyze the association genetic polymorphisms of glutathione S-transferase T1 (GSTT1) and smoking with genetic susceptibility to sporadic colorectal adenocarci-noma (SCRAC). METHODS: All subjects were unrelated Han people in Hubei province of China. Using multiplex PCR, we studied the genetic polymorphisms of the GSTT1 genes. RESULTS: The difference of frequency of GSTT1 null genotype between severely-smoking SCRAC and the severely-smoking controls reached statistical significance (X2=5.35, P =0.021). The frequency of GSTT1 null genotype was more common in the distal SCRAC with severely-smoking (X2=6.48, P =0.011), in the non-elder SCRAC with severely-smoking (X2=4.53, P =0.033), and in the poorly-differentiated SCRAC with severely-smoking (X2=4.02, P =0.045) when compared with the severely-smoking controls. On the other hand, compared with the severely-smoking controls, all the difference of frequency of GSTT1 null genotype in severely-smoking SCRAC with various Dukes stages did not reach statistical significance, respectively. CONCLUSION: The GSTT1 null genotype may augment the risk of SCRAC with severely-smoking, especially the non-elder patients, and most tumors are distal SCRACs and poorly-differentiated SCRAC.
出处 《世界华人消化杂志》 CAS 2004年第8期1806-1808,共3页 World Chinese Journal of Digestology
  • 相关文献

参考文献10

  • 1de Kok TM, van Maanen JM. Evaluation of fecal mutagenicity and colorectal cancer risk. Mutat Res 2000;463:53-101.
  • 2Setiawan VW, Zhang ZF, Yu GP, Li YL, Lu ML, Tsai CJ,Cordova D, Wang MR, Guo CH, Yu SZ, Kurtz RC. GSTT1 and GSTM1 null genotypes and the risk of gastric cancer: a case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prev 2000;9:73-80.
  • 3Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res 2000;463:247-283.
  • 4Zhang H, Ahmadi A, Arbman G, Zdolsek J, Carstensen J,Nordenskjold B, Soderkvist P, Sun XF. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer 1999;84:135-138.
  • 5Welfare M, Monesola-Adeokun A, Bassendine MF, Daly AK.Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev 1999;8:289-292.
  • 6Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K,Hunter DJ. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study.Cancer Epidemiol Biomarkers Prev 1998;7:1001-1005.
  • 7朱尤庆,邓长生,张友才,周新,贺小玲.谷胱甘肽S-转移酶M1、T1基因多态与散发性大肠腺癌遗传易感性[J].中华内科杂志,2002,41(8):538-540. 被引量:3
  • 8邓长生,张友才,林军,孙洁.毒物代谢酶基因多态性与结肠腺癌易感性关联[J].中华消化杂志,2003,23(9):540-543. 被引量:5
  • 9Inoue H, Kiyohara C, Marugame T, Shinomiya S, Tsuji E,Handa K, Hayabuchi H, Onuma K, Hamada H, Koga H,Kono S. Cigarette smoking, CYPIA1 MspI and GSTM1 genotypes, and colorectal adenomas. Cancer Res 2000;60:3749-3752.
  • 10Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, Willett WC. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 1994;86:183-191.

二级参考文献13

  • 1Rebbeck TA. Molecular epidemiology of the human glutathione Stransferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prey, 1997,6:733-743.
  • 2Hengstler JG, Arand M, Herrero ME, et al. Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res, 1998,154:47-85.
  • 3Setiawan VW, Zhang ZF, Yu GP, et al. GSTM1 and GSTT1 null genotypes and the risk of gastric cancer. A case-control study in a Chinese population. Cancer Epidemiol Biomarkers Prey, 2000,9:73-80.
  • 4Landi S. Mammalian class theta GST and differential susceptibility to carcinogens: a review. Mutat Res, 2000,463:247-283.
  • 5Hung CF, Chung JG, Liu SI, et al. Arylamine N-acetyltransferase: a possible promoter in Helicobacter pylori-related gastric carcinogenesis. Zhonghua Yi Xue Za Zhi (Taipei), 1999,62:203-208.
  • 6de Kok TM, van Maanen JM. Evaluation of fecal mutagenieity and colorectal cancer risk. Murat Res, 2000,463:53-101.
  • 7Sawada M, Kamataki T. Genetically engineered eels stably expressing cytochrome P450 and the it application to mutagen assays. Murat Res, 1998,411:19-43.
  • 8Katoh T, Nagata N, Kuroda Y, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTM1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis,1996,17 : 1855-1859.
  • 9Gertig DM, Stampfer M, Haiman C, et al. Glulathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev,1998,7:1001-1005.
  • 10Bell DA, Stephens EA, Castranio T, et al. Polyadenylation polymorphism in the acetyltransferase 1 gene( NAT1 ) increases risk of colorectal cancer. Cancer Res, 1995,55 : 3537-3542.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部